Skip to main content
Clinical Trials/DRKS00033498
DRKS00033498
Not yet recruiting
未知

Investigating the success of an app-led weight loss program

pfit GmbH & Co. KG0 sites60 target enrollmentMarch 1, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Overweight
Sponsor
pfit GmbH & Co. KG
Enrollment
60
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
pfit GmbH & Co. KG

Eligibility Criteria

Inclusion Criteria

  • Written informed consent of the study participants after detailed verbal and written explanation of the study content, requirements and risks
  • \- Ability and willingness to follow the investigator's instructions
  • \- BMI: 28\.0\-35\.0 kg/m2

Exclusion Criteria

  • \- Severe chronic diseases (diagnosed diabetes, cardiovascular diseases, liver diseases, renal insufficiency, cancer)
  • \- Chronic diseases of the gastrointestinal tract (especially small intestine, liver, pancreas) and condition following surgery on the gastrointestinal tract; e.g. gastrectomy, sprue, enterocolitis, chronic pancreatitis, cholestasis, short bowel syndrome, chronic inflammatory bowel disease, not: appendicitis, gallstone surgery
  • \- Surgical procedures to reduce the size of the stomach, gastric banding, gastric balloon
  • \- Autoimmune diseases (e.g. Crohn's disease, ulcerative colitis, rheumatoid arthritis, multiple sclerosis)
  • \- Regular intake of laxatives
  • \- Regular use of immunosuppressive medication (e.g. corticosteroids (except inhaled))
  • \- Pregnancy, breastfeeding period
  • \- Alcohol, drug and/or medication abuse
  • \- Immediate need for surgical intervention in the next 3 months
  • \- Simultaneous participation in another clinical trial or participation within the last 30 days

Outcomes

Primary Outcomes

Not specified

Similar Trials